Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 61

1.

Use of diagnostic tests in adolescents with essential hypertension.

Yoon EY, Cohn L, Rocchini A, Kershaw D, Freed G, Ascione F, Clark S.

Arch Pediatr Adolesc Med. 2012 Sep;166(9):857-62. doi: 10.1001/archpediatrics.2012.1173.

PMID:
22825544
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Left ventricle remodeling in men with moderate to severe volume-dependent hypertension.

Indra T, Holaj R, Zelinka T, Petrák O, Strauch B, Rosa J, Somlóová Z, Malík J, Janota T, Hradec J, Widimsky J Jr.

J Renin Angiotensin Aldosterone Syst. 2012 Dec;13(4):426-34. doi: 10.1177/1470320312446240. Epub 2012 May 29.

PMID:
22645061
[PubMed - indexed for MEDLINE]
3.

Telmisartan decreases atrial electromechanical delay in patients with newly diagnosed essential hypertension.

Sengul C, Cevik C, Ozveren O, Oduncu V, Sunbul A, Kılıcarslan F, Semiz E, Dindar I.

J Electrocardiol. 2012 Mar;45(2):123-8. doi: 10.1016/j.jelectrocard.2011.09.004. Epub 2011 Oct 20.

PMID:
22018835
[PubMed - indexed for MEDLINE]
4.

[Computerized interpretation of the electrocardiogram in the diagnosis of left ventricular hypertrophy. The ELECTROPRES project].

Barrios V, Calderón A, Coca A, González-Juanatey JR, Sarríá A, Rodríguez-Padial L.

Rev Clin Esp. 2011 Sep;211(8):391-9. doi: 10.1016/j.rce.2011.03.011. Epub 2011 May 14. Spanish.

PMID:
21571266
[PubMed - indexed for MEDLINE]
5.

Effect of telmisartan on QT interval variability and autonomic control in hypertensive patients with left ventricular hypertrophy.

Galetta F, Franzoni F, Fallahi P, Tocchini L, Graci F, Carpi A, Antonelli A, Santoro G.

Biomed Pharmacother. 2010 Oct;64(8):516-20. doi: 10.1016/j.biopha.2009.09.016. Epub 2009 Dec 9.

PMID:
20044234
[PubMed - indexed for MEDLINE]
6.

Factors to predict recurrence of atrial fibrillation in patients with hypertension.

Ma X, Zhang X, Guo W.

Clin Cardiol. 2009 May;32(5):264-8. doi: 10.1002/clc.20449.

PMID:
19452484
[PubMed - indexed for MEDLINE]
7.

Regression of echocardiographic left ventricular hypertrophy after 2 years of therapy reduces cardiovascular risk in patients with essential hypertension.

Pierdomenico SD, Lapenna D, Cuccurullo F.

Am J Hypertens. 2008 Apr;21(4):464-70. doi: 10.1038/ajh.2008.2. Epub 2008 Feb 7.

PMID:
18369364
[PubMed - indexed for MEDLINE]
8.

Clinical study with azelnidipine in patients with essential hypertension. Antiarteriosclerotic and cardiac hypertrophy-inhibitory effects and influence on autonomic nervous activity.

Nada T, Nomura M, Koshiba K, Kawano T, Mikawa J, Ito S.

Arzneimittelforschung. 2007;57(11):698-704. doi: 10.1055/s-0031-1296670.

PMID:
18193691
[PubMed - indexed for MEDLINE]
9.

Reduction of QTc dispersion by the angiotensin II receptor blocker valsartan may be related to its anti-oxidative stress effect in patients with essential hypertension.

Miyajima K, Minatoguchi S, Ito Y, Hukunishi M, Matsuno Y, Kakami M, Kawasaki M, Nishigaki K, Takemura G, Fujiwara H.

Hypertens Res. 2007 Apr;30(4):307-13.

PMID:
17541209
[PubMed - indexed for MEDLINE]
10.

[Evaluation of hypotensive and antiischemic effects of a combination of dihydropyridine and non-dihydropyridine calcium antagonists in patients suffering from coronary artery disease with arterial hypertension].

Iskendeerov BG, Burmistrova LF, Berenshteĭn NV, Abramova GN, Lokhina TV, Shibaeva TM.

Klin Med (Mosk). 2006;84(11):52-6. Russian.

PMID:
17243612
[PubMed - indexed for MEDLINE]
11.

Regression of left ventricular hypertrophy during antihypertensive treatment.

Foading Deffo B.

Acta Cardiol. 2006 Aug;61(4):485-8.

PMID:
16970062
[PubMed - indexed for MEDLINE]
12.

Isolated ambulatory hypertension and changes in target organ damage in treated hypertensive patients.

Cuspidi C, Meani S, Fusi V, Valerio C, Catini E, Magrini F, Zanchetti A.

J Hum Hypertens. 2005 Jun;19(6):471-7.

PMID:
15744331
[PubMed - indexed for MEDLINE]
13.

Markers of collagen synthesis is related to blood pressure and vascular hypertrophy: a LIFE substudy.

Olsen MH, Christensen MK, Wachtell K, Tuxen C, Fossum E, Bang LE, Wiinberg N, Devereux RB, Kjeldsen SE, Hildebrandt P, Dige-Petersen H, Rokkedal J, Ibsen H.

J Hum Hypertens. 2005 Apr;19(4):301-7.

PMID:
15647776
[PubMed - indexed for MEDLINE]
14.

Prognostic significance of left ventricular mass change during treatment of hypertension.

Devereux RB, Wachtell K, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris K, Aurup P, Dahlöf B.

JAMA. 2004 Nov 17;292(19):2350-6.

PMID:
15547162
[PubMed - indexed for MEDLINE]
15.

Sympathetic and baroreflex function in hypertensive or heart failure patients with ventricular arrhythmias.

Grassi G, Seravalle G, Dell'Oro R, Facchini A, Ilardo V, Mancia G.

J Hypertens. 2004 Sep;22(9):1747-53.

PMID:
15311103
[PubMed - indexed for MEDLINE]
16.

Effect of irbesartan versus atenolol on left ventricular mass and voltage: results of the CardioVascular Irbesartan Project.

Schneider MP, Klingbeil AU, Delles C, Ludwig M, Kolloch RE, Krekler M, Stumpe KO, Schmieder RE.

Hypertension. 2004 Jul;44(1):61-6. Epub 2004 Jun 7.

PMID:
15184349
[PubMed - indexed for MEDLINE]
Free Article
18.

Relationship between left ventricular mass and blood pressure in treated hypertension.

Missault LH, De Buyzere ML, De Bacquer DD, Duprez DD, Clement DL.

J Hum Hypertens. 2002 Jan;16(1):61-6.

PMID:
11840231
[PubMed - indexed for MEDLINE]
Free Article
19.

Essential hypertension: the heart and hypertension.

Berkin KE, Ball SG.

Heart. 2001 Oct;86(4):467-75. Review. No abstract available.

PMID:
11559694
[PubMed - indexed for MEDLINE]
Free PMC Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk